SG Americas Securities
STIM icon

SG Americas Securities’s Neuronetics STIM Stock Holding History

SG Americas Securities’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,048
Closed -$62K – 3288
2024
Q1 		$62K Buy
+13,048
New +$45.9K ﹤0.01% 2700

Other funds holding STIM

ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

SG Americas Securities's STIM Position: Q2 2024 in Review

SG Americas Securities sold out of Neuronetics (STIM) in Q2 2024, closing a stake of 13,048 shares — an estimated $62K sold.

SG Americas Securities first reported a position in STIM in Q1 2024 and held it in 1 quarter. The position peaked at $62K in Q1 2024. 67 funds tracked by Wall St. Rank hold STIM as of Q2 2024.

  • SG Americas Securities reported no remaining Neuronetics position as of Q2 2024 after selling out during the quarter.
  • SG Americas Securities sold 13,048 Neuronetics shares in Q2 2024, an estimated $62K.
  • SG Americas Securities first reported a position in Neuronetics in Q1 2024 and held it in 1 quarter.
  • SG Americas Securities's Neuronetics position peaked at $62K in Q1 2024.
  • 67 funds tracked by Wall St. Rank held Neuronetics as of Q2 2024.

Based on SG Americas Securities's 13F filing for Q2 2024, filed 12 Jul 2024.